1-20 of 105 results for subject:Cancer
Librarians' tools
- Search time
- 0.253 seconds
- Solr query time
- 0.007 seconds
- Search query
- subject:Cancer
- We searched for
- subject_t:Cancer OR subject_t:Oncology OR subject_t:Sarcoma OR subject_ses:8937
Type
House
Session
Year
Department
Member
More
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
That this House marks World Cancer Day by recognising the urgent need to improve the early detection of breast cancer in younger women; notes with concern that breast cancer accounts for 43 per cent of all cancers diagnosed in women aged 25 to 49 years; further notes that breast cancer in younger women is often more aggressive and more likely to be diagnosed at a later stage, leading to poorer outcomes; pays tribute to campaigners and patients, including those whose symptoms were dismissed or misdiagnosed due to age; commends healthcare professionals providing high-quality care; and calls on the Government to urgently review the current breast cancer screening programme, including the merits of moving towards a more personalised, risk-based approach to screening, lowering the routine screening age for higher-risk groups, improving access to supplementary screening methods, ensuring faster referral pathways for symptomatic women, and addressing inequalities in outcomes so that all women, regardless of age or background, have the best possible chance of early diagnosis and survival.
That this House marks World Cancer Day by recognising the urgent need to improve the early detection of breast cancer in younger women; notes with concern that breast cancer accounts for 43 per cent of all cancers diagnosed in women aged 25 to 49 years; further notes that breast cancer...
That this House notes Less Survivable Cancers Week, which highlights cancers with a five-year survival rate of less than 50 per cent, including pancreatic, oesophageal, stomach, liver, lung and brain cancers; recognises that, together, these cancers account for a significant proportion of cancer deaths in the UK despite receiving a disproportionately low share of research funding; supports the standardised freezing and storage of tumour tissue for all cancer patients, often referred to as Owain’s Law, to ensure access to future treatments, research opportunities and advanced diagnostics; and calls on the Government for improved awareness, faster diagnostic pathways and increased investment in early detection and intervention.
That this House notes Less Survivable Cancers Week, which highlights cancers with a five-year survival rate of less than 50 per cent, including pancreatic, oesophageal, stomach, liver, lung and brain cancers; recognises that, together, these cancers account for a significant proportion of cancer deaths in the UK despite receiving a...
Yesterday the hon. Member outlined the tremendous work being done to privately raise about £1 million for research. Does she agree that that needs to be supplemented and complemented by statutory funding to make the dramatic difference that she, and hopefully all of us, agree needs to happen?
Yesterday the hon. Member outlined the tremendous work being done to privately raise about £1 million for research. Does she agree that that needs to be supplemented and complemented by statutory funding to make the dramatic difference that she, and hopefully all of us, agree needs to happen?
I have personal experience of a very young constituent who lost her father for the exact same reason. The trauma affects not just the immediate family, but close friends too, and it lives with them for years. Hopefully, we can see some progress both today and in the next few...
I have personal experience of a very young constituent who lost her father for the exact same reason. The trauma affects not just the immediate family, but close friends too, and it lives with them for years. Hopefully, we can see some progress both today and in the next few...
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the effectiveness of the NHS England Help Us Help You campaign on cancer symptom awareness.
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the effectiveness of the NHS England Help Us Help You campaign on cancer symptom awareness.
The Department and NHS England recognise the importance of directly targeting awareness campaigns at areas that we know will make a difference, to increase awareness of cancer symptoms and encourage people to get checked.
NHS England runs Help Us Help You campaigns to increase knowledge of cancer symptoms and to address the barriers to acting on them, to encourage people to come forward as soon as possible to see their general practitioner. The campaigns are evaluated in line with best practice, considering media metrics, campaign awareness, understanding and intention to act, along with analysis of operational data.
The most recent phases of Help Us Help You, which ran between January and March 2025, saw increases in symptom knowledge and intention to act. NHS England is undertaking operational data analysis, with early data showing an increase in cancer diagnosis at the same time as campaign activity. The campaigns focus on a range of symptoms, as well as encouraging body awareness to help people spot symptoms across a wide range of cancers at an earlier point.
I congratulate the hon. Member on the timeliness of her debate. Does she agree that we need more research on the health costs endured by society and the NHS due to this problem? That has to be offset against the tax revenues that accrue from alcohol overconsumption. Those things have...
I congratulate the hon. Member on the timeliness of her debate. Does she agree that we need more research on the health costs endured by society and the NHS due to this problem? That has to be offset against the tax revenues that accrue from alcohol overconsumption. Those things have...
My hon. Friend is talking about an educational approach and trying to advise rather than force people; does he agree that the younger we start doing that, the better? Although they are not exclusively the target audience, we need to focus on teenagers and those in their early 20s, because...
My hon. Friend is talking about an educational approach and trying to advise rather than force people; does he agree that the younger we start doing that, the better? Although they are not exclusively the target audience, we need to focus on teenagers and those in their early 20s, because...
That this House marks Sarcoma Awareness Month 2025, celebrated in July, which raises awareness about Sarcoma, a rare type of cancer that develops in soft bones and tissues; notes the theme of this year's awareness is early diagnosis and educating the public on the most common of symptoms and the life of people dealing with the impacts it can have; highlights that approximately 5,300 people are diagnosed with Sarcoma in the UK each year, making up 2% of all cancers diagnosed in the UK each year; underlines that Sarcoma is often referred to as the loneliest cancer because it has over 100 different subtypes and people with it often never meet someone with the same subtype; thanks Sarcoma UK and other charities for their work in ensuring support is available for people diagnosed with sarcoma; and encourages the Government to ensure that it delivers high-quality care for people with sarcoma in the future.
That this House marks Sarcoma Awareness Month 2025, celebrated in July, which raises awareness about Sarcoma, a rare type of cancer that develops in soft bones and tissues; notes the theme of this year's awareness is early diagnosis and educating the public on the most common of symptoms and the...
That this House recognises the unimaginable pain experienced by families receiving a childhood cancer diagnosis; pays heartfelt tribute to David and Sara Watson, who, following the devastating loss of their much loved son Adam, have channelled their grief into tireless campaigning to support other families on this harrowing journey; notes with deep concern the current delay of up to three months in accessing Child Disability Living Allowance (DLA) following a cancer diagnosis, despite the immediate and overwhelming needs of the child and their family; supports the call for urgent legislative reform through Adam’s Law, which would ensure automatic and immediate access to Child DLA upon diagnosis of childhood cancer; commends the work of the charity B Positive in advocating for improved wraparound support services; and urges the Government to act without delay to deliver compassionate, timely, and effective support to families facing the trauma of childhood cancer.
That this House recognises the unimaginable pain experienced by families receiving a childhood cancer diagnosis; pays heartfelt tribute to David and Sara Watson, who, following the devastating loss of their much loved son Adam, have channelled their grief into tireless campaigning to support other families on this harrowing journey; notes...
To ask the Secretary of State for Health and Social Care, what her timetable is for the introduction of the recommendations of the final evaluation report for the secondary care routine reflux cohort of the Cytosponge test.
To ask the Secretary of State for Health and Social Care, what her timetable is for the introduction of the recommendations of the final evaluation report for the secondary care routine reflux cohort of the Cytosponge test.
On 26 February 2024, NHS England published the results of the cytosponge test pilot for secondary care routine reflux and Barrett’s surveillance cohort, which began in January 2021, and launched at 30 hospitals across England. The pilot tested over 8,500 patients with the capsule sponge test. Evaluation of a cohort of patients showed almost eight out of 10 patients, who completed a test, were discharged without the need for further testing, freeing up endoscopy capacity for higher risk patients and those referred for urgent tests for oesophageal cancer. Patients with positive results from the capsule sponge test who were referred on for an endoscopy had the highest prevalence of Barrett’s oesophagus, at 27.2%, compared to zero patients with negative results who completed an endoscopy.
A timetable for the introduction of the recommendations of the final evaluation report for the secondary care routine reflux cohort of the cytosponge test, is yet to be finalised and published.
That this House notes the Young Lives vs Cancer report entitled Running on Empty which explores the costs that young cancer patients and their families face when travelling for treatment; expresses concern at the finding in the report that it costs young cancer patients and their families on average £250 per month and, depending on their location, can be far higher in some cases; expresses strong concern that, consequently, 27 per cent are having to cut back on food, 20 per cent are falling behind in paying bills, 20 per cent are having to sell their possessions, 10 per cent are having to delay or miss treatment and, in some cases, are having to give up their homes as they are unable to meet housing costs; further notes the report's conclusion that the current support available is inadequate with only 12 per cent of families receiving any support to cover travel costs; and supports Young Lives vs Cancer's call for the establishment of a Government-funded young cancer patient travel fund to address this unfairness.
That this House notes the Young Lives vs Cancer report entitled Running on Empty which explores the costs that young cancer patients and their families face when travelling for treatment; expresses concern at the finding in the report that it costs young cancer patients and their families on average £250...
To ask the Secretary of State for Health and Social Care, when he plans to publish the final evaluation report for the secondary care routine reflux cohort of the Cytosponge test.
To ask the Secretary of State for Health and Social Care, when he plans to publish the final evaluation report for the secondary care routine reflux cohort of the Cytosponge test.
NHS England is currently finalising and approving the evaluation report before publication. Once approved the report will be published.
To ask the Secretary of State for Health and Social Care, if he will hold discussions with health ministers in (a) Scotland, (b) Wales and (c) Northern Ireland on reaching a consensus on having 75 per cent of cancers diagnosed within the first two stages across the UK.
To ask the Secretary of State for Health and Social Care, if he will hold discussions with health ministers in (a) Scotland, (b) Wales and (c) Northern Ireland on reaching a consensus on having 75 per cent of cancers diagnosed within the first two stages across the UK.
We have no current plans to do so. While the NHS Long Term Plan commits to diagnosing 75% of cancers in England at an early stage by 2028, in other parts of the United Kingdom this is a devolved matter. The Department engages in sharing best practice between the devolved administrations.
To ask the Secretary of State for Health and Social Care, when NICE plans to publish the outcome of its assessment of the effectiveness of Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer.
To ask the Secretary of State for Health and Social Care, when NICE plans to publish the outcome of its assessment of the effectiveness of Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer.
In February 2021, the National Institute for Health and Care Excellence issued final guidance that recommends niraparib for use within the Cancer Drugs Fund (CDF) for the maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy. Niraparib is now available to eligible National Health Service patients in England through the CDF in line with this recommendation.
To ask the Secretary of State for Health and Social Care, whether it remains his policy increase diagnosis of the 10 most common cancers at stages 1 and 2 to 75 percent by 2028.
To ask the Secretary of State for Health and Social Care, whether it remains his policy increase diagnosis of the 10 most common cancers at stages 1 and 2 to 75 percent by 2028.
The NHS Long Term Plan commitments remain in place despite the COVID-19 pandemic. This includes the commitment of staging 75% of all cancers at stage 1 or 2.
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, what the daily death rate was from (a) cancer, (b) dementia (c) Alzheimer's disease, (d) coronary heart disease, (e) stroke and (f) covid-19 in the latest period for which figures are available.
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, what the daily death rate was from (a) cancer, (b) dementia (c) Alzheimer's disease, (d) coronary heart disease, (e) stroke and (f) covid-19 in the latest period for which figures are available.
The information requested falls under the remit of the UK Statistics Authority. I have therefore asked the Authority to respond.
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, how many people died from (a) coronary heart disease, (b) stroke, (c) prostate cancer, (d) breast cancer and (e) bowel cancer from 1 April to 1 August in (i) 2016, (ii) 2017, (iii) 2018, (iv)...
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, how many people died from (a) coronary heart disease, (b) stroke, (c) prostate cancer, (d) breast cancer and (e) bowel cancer from 1 April to 1 August in (i) 2016, (ii) 2017, (iii) 2018, (iv)...
The information requested falls under the remit of the UK Statistics Authority. I have therefore asked the Authority to respond.
To ask the Secretary of State for Health and Social Care, with reference to the news story entitled, Early cancer detection and survival to be prioritised by NHS, published by his Department in July 2019, if he will make it his policy to publish regular progress reports on the Government's...
To ask the Secretary of State for Health and Social Care, with reference to the news story entitled, Early cancer detection and survival to be prioritised by NHS, published by his Department in July 2019, if he will make it his policy to publish regular progress reports on the Government's...
The National Cancer Registration and Analysis Service (NCRAS) are currently developing a new early diagnosis metric which will be used specifically to track progress towards the 75% ambition. This new metric will provide a more comprehensive measure of early diagnosis, including more cancer sites than the current available measures.
This metric will be regularly reported on the NCRAS website.
To ask the Secretary of State for Health and Social Care, if he will hold discussions with his counterparts in the devolved regions on recent changes in rates of cancer involving children to ensure reductions in all parts of the UK.
To ask the Secretary of State for Health and Social Care, if he will hold discussions with his counterparts in the devolved regions on recent changes in rates of cancer involving children to ensure reductions in all parts of the UK.
Health and social care, including cancer treatment and care, is a devolved matter. As such, no discussions are currently planned.
To ask the Secretary of State for Health and Social Care, if he will hold discussions with his counterparts in the devolved administrations on the variation in rates of children diagnosed with cancer across the UK.
To ask the Secretary of State for Health and Social Care, if he will hold discussions with his counterparts in the devolved administrations on the variation in rates of children diagnosed with cancer across the UK.
No such discussions are planned. NHS England is currently out to consultation on new service specifications for children's cancer services in England. Further information is available at the following link:
https://www.engage.england.nhs.uk/consultation/childrens-cancer-services
The consultation closes on 4 August 2019.